News Link: Pfizer Covid Vaccine is 90% Effective – Claims Company
Pfizer Inc’s (PFE.N) experimental COVID-19 vaccine is more than 90% effective based on initial trial results the drugmaker said on Monday. A major victory in the war against a virus that has killed over a million people and battered the world’s economy.
Experts welcomed the first successful interim data from a large-scale clinical test as a watershed moment that showed vaccines could help halt the pandemic, although mass roll-outs, which needs regulatory approval, will not happen this year.
Pfizer and German partner BioNTech SE (22UAy.F) said they had found no serious safety concerns yet. And expected to seek U.S. authorization this month for emergency use of the vaccine, raising the chance of a regulatory decision as soon as December.
If granted, the companies estimate they can roll out up to 50 million doses this year, enough to protect 25 million people, and then produce up to 1.3 billion doses in 2021.
Experts said they still wanted to see the full trial data, which have yet to be peer-reviewed or published in a medical journal. But the preliminary results are encouraging.
There are still many questions, such as how effective the vaccine is by ethnicity or age. And how long it will provide immunity, with the “new normal” of social distancing and face covering set to remain for the foreseeable future.
The World Health Organization said the results were very positive. But warned there was a funding gap of $4.5 billion that could slow access to tests, medicines and vaccines in low- and middle-income countries.
Compiled by – MK (Editor)
Read More news at Health Segment
News Link: Pfizer Covid Vaccine is 90% Effective – Claims Company
